Swiss wearable glucose-monitoring technology startup Liom closes €13.9 million round

Schwyz-based Liom, a pioneer in non-invasive biomarker tracking and the programmer of a non-invasive glucose-monitoring wearable, introduced a EUR13.9 million (CHF 13 million) expansion of its Collection A funding round.

The round was led by previous lead capitalists, with brand-new engagement from Red Bull Ventures, Marc Maurer (previous co-CEO of On Operating), Melih Odemis (previous founder and CTO of Yemeksepeti), Alejo Costa Ribalta, companion of financial backing company CRB Health and wellness Technology and previous elderly exec of Philips and GE Medical care– bringing its complete Collection A to EUR40.8 million (CHF 38 million) and its complete financing to day to EUR67.6 million (CHF 63 million).

“ Currently, we can additionally make certain that we have actually not just shown the approach, yet we had the appropriate group and the correct amount of good luck to produce the called for advancement advancements in order to bring our system right into a wearable-fitting form-factor,” states Leo Grünstein, creator and chief executive officer of Liom.

In 2025, European HealthTech start-ups concentrating on wearables, biosensing, and preventative treatment have actually brought in noteworthy financial backing, showing financier self-confidence in innovations that provide constant health and wellness understandings past conventional professional setups.

As an example, Sava Technologies Ltd., a London-based MedTech pioneer in real-time molecular wearable sensing units, increased EUR16.6 million in Collection A to progress governing authorization and commercialisation of its next-generation gadget, bringing its complete financing to virtually EUR28 million. In surrounding preventative treatment domain names, Lucis safeguarded EUR7.2 million in Seed financing to broaden its biomarker-based health and wellness analytics system throughout Europe, and GlycanAge increased EUR7.4 million to scale its glycan-based diagnostics for preventative aging treatment.

With Each Other, these 2025 rounds highlight a financing environment where about EUR31 million is being assigned towards start-ups establishing constant tracking, customised metabolic understanding devices, and preventative diagnostics that rest along with Liom’s non-invasive sugar wearable advancement.

“ Our miniaturisation advancement substantially boosts light throughput versus existing advanced options– also outmatching table-sized lab-scale tools by 12x– and keeping that opens prior undetected efficiency, a > 24h battery life, smartwatch sizing and manufacturability at range” Grünstein includes.

Established In 2017 by Leo Grünstein, Liom Health and wellness (previously Spiden) is a Swiss HealthTech start-up introducing preventative and customised health and wellness tracking with an unique wearable that informs customers with real-time biophysical comments.

Liom’s very first item, anticipated to release in 2028, is a non-invasive glucose-monitoring wearable that supplies an extensive sight of metabolic health and wellness.

The brand-new resources complies with Liom’s current advancement in miniaturising its exclusive Raman spectroscopy system, having actually shown its capability to determine sugar non-invasively and as the globe’s only firm calibration-free, i.e. needing no needles to adjust whatsoever, on over 130 topics during the previous years.

Liom is additionally inviting Marc Maurer, previous co-CEO of On Running– a Swiss success tale valued at greater than EUR11.8 billion (CHF 11 billion)– as both financier and Board participant. Marc brings know-how in item, customer worth development, in addition to branding and advertising, specifically at the junction of health and wellness, physical fitness and customer items.

His know-how will certainly sustain Liom as it changes from R&D right into item advancement and commercialisation.

Maurer states: “ Nourishment and activity are definitely essential to a top quality of life. Having accessibility to sugar dimensions with a wearable on your wrist, without the demand for a needle, will certainly permit everyone to comprehend the influence of nourishment and activity on our body better and consequently live a much healthier life. Liom opens mass-adoption by customers & professional athletes vs existing microneedle CGM tools.

” I think Liom has the prospective to interfere with and substantially broaden the wearable market that has actually been developed by Apple Watch, Samsung Galaxy Watch, Fitbit, Garmin, Whoop, Oura, and so on– yet hasn’t seen sensor-level advancement over the previous years.“

The blog post Swiss wearable glucose-monitoring technology startup Liom closes €13.9 million round showed up initially on EU-Startups.